Breaking News Instant updates and real-time market news.

CHRS

Coherus Biosciences

$22.76

-0.61 (-2.61%)

09:32
07/08/19
07/08
09:32
07/08/19
09:32

Coherus Biosciences sees Q2 preliminary UDENYCA net sales $79M-$84M

Coherus BioSciences announced that UDENYCA preliminary unaudited net sales for the quarter that ended June 30 are expected to be in the range of $79M-$84M. Coherus will not disclose topline gross sales, discounts, or gross-to-net data until these data are reported in its Form 10-Q for the quarter ended June 30.

  • 10

    Jul

CHRS Coherus Biosciences
$22.76

-0.61 (-2.61%)

08/28/18
HCWC
08/28/18
INITIATION
Target $28
HCWC
Buy
Coherus Biosciences initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Jason Kolbert started Coherus Biosciences (CHRS) with a Buy rating and $28 price target. The analyst expects approval of the company's Udencya in both the U.S. and Europe this year. His confidence level is driven by a positive recommendation from the European Committee for Medicinal Products for Human Use in July for marketing authorization of Udencya, a biosimilar compound targeting febrile neutropenia. Coherus announced that the committee reviewed all the new immunogenicity data that were required for the U.S. re-submission too, so the EU recommendation for approval adds a measure of confidence in support of U.S. approval, Kolbert tells investors in a research note. A year-end approval should position Udencya as the second biosimilar in the $4B U.S. marketplace behind Mylan (MYL), which should be launching its product following approval in June, the analyst adds.
05/07/19
HCWC
05/07/19
INITIATION
Target $28
HCWC
Buy
Coherus Biosciences initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Douglas Tsao started Coherus Biosciences with a Buy rating and $28 price target. A fast launch for first product Udenyca, a biosimilar to Amgen's Neulasta, bodes well for long-term value creation, Tsao tells investors in a research note.
06/11/19
LEHM
06/11/19
INITIATION
Target $30
LEHM
Overweight
Coherus Biosciences initiated with an Overweight at Barclays
Barclays analyst Balaji Prasad started Coherus Biosciences with an Overweight rating and $30 price target. The analyst launched coverage of 20 U.S. Specialty Pharmaceuticals with a Neutral industry view. He placed importance on cash flows and companies' ability to manage leverage and improve balance sheets.
06/21/19
LEHM
06/21/19
NO CHANGE
Target $30
LEHM
Overweight
Coherus Biosciences is in 'a league of its own,' says Barclays
After hosting a meeting with management, Barclays analyst Balaji Prasad says Coherus Biosciences is in "a league of its own, having cracked the commercial code." The analyst now has greater confidence in his projected 22% annual Udenyca sales growth through 2023. He expects Udenyca to reach $400M-plus in 2023 and reiterates an Overweight rating on Coherus shares with a $30 price target. The company's additional pipeline opportunities are also underappreciated, Prasad tells investors in a research note.

TODAY'S FREE FLY STORIES

SPLK

Splunk

$118.43

-10.08 (-7.84%)

08:00
08/23/19
08/23
08:00
08/23/19
08:00
Recommendations
Splunk analyst commentary  »

Splunk may become an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 15

    Oct

ATRC

AtriCure

$26.74

-0.46 (-1.69%)

08:00
08/23/19
08/23
08:00
08/23/19
08:00
Conference/Events
AtriCure participates in a conference call with SVB Leerink »

SVB Leerink holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 17

    Sep

  • 18

    Sep

07:55
08/23/19
08/23
07:55
08/23/19
07:55
General news
Fed's Bullard remains worried about low inflation and downside risks to the economy »

Fed's Bullard…

AMRC

Ameresco

$14.62

-0.11 (-0.75%)

07:54
08/23/19
08/23
07:54
08/23/19
07:54
Conference/Events
Cowen alternative energy analyst to hold analyst/industry conference call »

Alternative Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

ATGE

Adtalem Global Education

$50.93

-0.37 (-0.72%)

07:54
08/23/19
08/23
07:54
08/23/19
07:54
Recommendations
Adtalem Global Education analyst commentary  »

Adtalem Global Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

CERN

Cerner

$71.62

-0.15 (-0.21%)

07:52
08/23/19
08/23
07:52
08/23/19
07:52
Downgrade
Cerner rating change  »

Cerner downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

UIS

Unisys

$7.70

-0.04 (-0.52%)

07:52
08/23/19
08/23
07:52
08/23/19
07:52
Hot Stocks
Unisys awarded contract valued at up to $25M by state of Georgia »

Unisys announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

07:52
08/23/19
08/23
07:52
08/23/19
07:52
Conference/Events
BTIG healthcare analysts to hold an analyst/industry conference call »

Healthcare Analysts,…

LYFT

Lyft

$51.31

-2.83 (-5.23%)

07:51
08/23/19
08/23
07:51
08/23/19
07:51
Recommendations
Lyft analyst commentary  »

JPMorgan keeps Overweight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

07:49
08/23/19
08/23
07:49
08/23/19
07:49
Conference/Events
CLSA Asian tech analysts to hold an analyst/industry conference call »

Asian Technology Analysts…

LNDC

Landec

$10.99

-0.07 (-0.63%)

07:48
08/23/19
08/23
07:48
08/23/19
07:48
Initiation
Landec initiated at DA Davidson »

Landec initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

07:41
08/23/19
08/23
07:41
08/23/19
07:41
Recommendations
VMware, Pivotal Software, Carbon Black analyst commentary at Barclays »

VMware investors will…

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

WMT

Walmart

$111.90

-0.11 (-0.10%)

, TSLA

Tesla

$222.07

1.18 (0.53%)

07:39
08/23/19
08/23
07:39
08/23/19
07:39
Periodicals
Walmart, Tesla seek to resolve issues surrounding solar systems, Reuters reports »

Walmart (WMT) and Tesla…

WMT

Walmart

$111.90

-0.11 (-0.10%)

TSLA

Tesla

$222.07

1.18 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 23

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

AAPL

Apple

$212.55

-0.14 (-0.07%)

07:38
08/23/19
08/23
07:38
08/23/19
07:38
Periodicals
Apple contractors listened to 1,000 Siri recordings a day, Irish Examiner says »

Jess Casey of the Irish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$19.33

-0.72 (-3.59%)

07:36
08/23/19
08/23
07:36
08/23/19
07:36
Recommendations
L Brands analyst commentary at Bernstein »

L Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 21

    Nov

CRM

Salesforce

$148.26

0.86 (0.58%)

07:36
08/23/19
08/23
07:36
08/23/19
07:36
Recommendations
Salesforce analyst commentary at RBC Capital »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

BBBY

Bed Bath & Beyond

$8.75

0.77 (9.65%)

, MDR

McDermott

$4.39

0.24 (5.78%)

07:35
08/23/19
08/23
07:35
08/23/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BBBY

Bed Bath & Beyond

$8.75

0.77 (9.65%)

MDR

McDermott

$4.39

0.24 (5.78%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

DKS

Dick's Sporting

$34.14

1.17 (3.55%)

07:34
08/23/19
08/23
07:34
08/23/19
07:34
Recommendations
Dick's Sporting analyst commentary at Susquehanna »

Dick's Sporting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

RTRX

Retrophin

$13.55

-3.84 (-22.08%)

07:29
08/23/19
08/23
07:29
08/23/19
07:29
Recommendations
Retrophin analyst commentary at Barclays »

Retrophin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

07:28
08/23/19
08/23
07:28
08/23/19
07:28
Recommendations
VMware, Pivotal Software, Carbon Black analyst commentary at RBC Capital »

VMware price target…

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

CRM

Salesforce

$148.26

0.86 (0.58%)

07:28
08/23/19
08/23
07:28
08/23/19
07:28
Recommendations
Salesforce analyst commentary at Canaccord »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

07:27
08/23/19
08/23
07:27
08/23/19
07:27
Conference/Events
Federal Reserve Chairman Jerome Powell speaks at symposium »

Federal Reserve Chairman…

07:24
08/23/19
08/23
07:24
08/23/19
07:24
Conference/Events
Federal Reserve Bank of St. Louis president to be interviewed »

James Bullard, President…

INTU

Intuit

$276.05

-0.29 (-0.10%)

07:24
08/23/19
08/23
07:24
08/23/19
07:24
Recommendations
Intuit analyst commentary at Credit Suisse »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

TGI

Triumph Group

$22.70

0.19 (0.84%)

07:22
08/23/19
08/23
07:22
08/23/19
07:22
Downgrade
Triumph Group rating change at Barclays »

Triumph Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.